Letters Breakthrough cancer pain
Morphine remains gold standard in breakthrough cancer painBMJ 2008; 337 doi: https://doi.org/10.1136/bmj.a3104 (Published 24 December 2008) Cite this as: BMJ 2008;337:a3104
View Full Text
- Vicente Ruiz-Garcia1,
- Eduardo Lopez-Briz1
- 1Home Hospitalisation Unit, HU La Fe, 46014 Valencia, Spain
Although Davies and colleagues argue that little evidence supports the unlicensed use of oral morphine,1 morphine remains the gold standard in cancer pain. Licensed or unlicensed use is a transient status, especially in palliative care. Little evidence may support the use of oral …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.